Pattern of Care of Recurrent Cervical Cancer in Low-resource Settings: Challenges and Patient-initiated Follow-up as a Novel Opportunity

被引:0
作者
Barmon, Debabrata [1 ]
Tak, Apoorva [1 ,5 ]
Baruah, Upasana [1 ,5 ]
Begum, Dimpy [1 ]
Gupta, Sakshi [2 ]
Khanikar, Duncan [3 ]
Nath, Jyotiman [4 ]
Yadav, Garima [6 ]
机构
[1] Dr Bhubaneswar Canc Inst, Dept Gynecol Oncol, Gauhati, India
[2] Dr Bhubaneswar Canc Inst, Dept Oncopathol, Mumbai, Maharashtra, India
[3] Dr Bhubaneswar Canc Inst, Dept Med Oncol, Mumbai, Maharashtra, India
[4] Dr Bhubaneswar Canc Inst, Dept Radiat Oncol, Mumbai, Maharashtra, India
[5] Tata Mem Hosp, Mumbai, Maharashtra, India
[6] AIIMS, Dept Obstet & Gynaecol, Jodhpur, Rajasthan, India
关键词
Cost benefit; patient-initiated follow-up; recurrent cervical cancer; PROGNOSTIC-FACTORS; DIAGNOSIS; MULTICENTER; SOCIETY; WOMEN;
D O I
10.4103/jmh.jmh_103_23
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Introduction: The availability of optimum diagnostic strategies remains a major problem in resource-constraint countries. This technique of patient-initiated follow-up (PIFU) has been recently adopted in the UK for gynecological cancers and has proven cost benefits. However, no study from the Indian subcontinent has ever been reported. Aims and Objectives: The primary objective was to study the pattern of care of recurrent cervical cancer in low-resource settings. The secondary objective was to compare the reliability of symptomatology/clinical evaluation and imaging methods on follow-up to detect recurrence and thus explore the feasibility of symptom-based PIFU. Materials and Methods: This was a single-institutional retrospective analysis of recurrent cervical cancer cases for a period of 3 years from January 2019 to January 2022. Patients who followed up for minimum of 6 months were included in the study. Results: In 57 of the total 69 patients, symptoms alone were the index diagnostic method. Interestingly, neither of the methods of recurrence detection had impact on overall survival (OS). Cox regression analysis revealed adverse impact of erratic/lost to follow-up (hazard ratio [HR] = 3.8) and pelvic side wall disease (HR = 1.33) on survival. Patients with positive para-aortic nodes had significantly shorter disease-free interval of 11 months, so adding systemic therapy to adjuvant treatment in this cohort needs to be further investigated. Conclusion: Our analysis showed that patients with recurrence who were diagnosed with clinical manifestations alone vis-& agrave;-vis the ones who were diagnosed primarily on routine follow-up visit by some imaging or diagnostic test had comparable oncologic outcomes. PIFU can be a "practice changing modality" in patient management system, especially in low-resource settings. It will prove to be a simple cost-effective method to detect recurrence and prevent fallouts. Our study points to the feasibility of PIFU in Indian scenario.
引用
收藏
页码:205 / 211
页数:7
相关论文
共 27 条
  • [1] Acharya S., 2014, J Res Med Den Sci, V13, P32
  • [2] Comparing hospital and telephone follow-up for patients treated for stage-I endometrial cancer (ENDCAT trial): a randomised, multicentre, non-inferiority trial
    Beaver, K.
    Williamson, S.
    Sutton, C.
    Hollingworth, W.
    Gardner, A.
    Allton, B.
    Abdel-Aty, M.
    Blackwood, K.
    Burns, S.
    Curwen, D.
    Ghani, R.
    Keating, P.
    Murray, S.
    Tomlinson, A.
    Walker, B.
    Willett, M.
    Wood, N.
    Martin-Hirsch, P.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2017, 124 (01) : 150 - 160
  • [3] Selection of Treatment Regimens for Recurrent Cervical Cancer
    Chao, Xiaopei
    Song, Xiaochen
    Wu, Huanwen
    You, Yan
    Wu, Ming
    Li, Lei
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [4] Patient initiated follow up after gynaecological malignancy: National survey of current UK practice
    Coleman, Laura
    Newton, Claire
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2020, 248 : 193 - 197
  • [6] Added value of para-aortic surgical staging compared to 18F-FDG PET/CT on the external beam radiation field for patients with locally advanced cervical cancer: An ONCO-GF study
    De Cuypere, Marjolein
    Lovinfosse, Pierre
    Goffin, Frederic
    Gennigens, Christine
    Rovira, Ramon
    Duch, Joan
    Fastrez, Maxime
    Gebhart, Geraldine
    Squifflet, Jean Luc
    Luyckx, Mathieu
    Charaf, Gabriel
    Crener, Kurt
    Buxant, Frederic
    Bucella, Dario
    Jouret, Mathieu
    Hustinx, Roland
    Kridelka, Frederic
    [J]. EJSO, 2020, 46 (05): : 883 - 887
  • [7] Recurrent cervical cancer: detection and prognosis
    Duyn, A
    Van Eijkeren, M
    Kenter, G
    Zwinderman, K
    Ansink, A
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2002, 81 (04) : 351 - 355
  • [8] Follow-up care after treatment for prostate cancer: evaluation of a supported self-management and remote surveillance programme
    Frankland, Jane
    Brodie, Hazel
    Cooke, Deborah
    Foster, Claire
    Foster, Rebecca
    Gage, Heather
    Jordan, Jake
    Mesa-Eguiagaray, Ines
    Pickering, Ruth
    Richardson, Alison
    [J]. BMC CANCER, 2019, 19 (1)
  • [9] Bevacizumab for recurrent, persistent or advanced cervical cancer: reproducibility of GOG 240 study results in "real world" patients
    Godoy-Ortiz, A.
    Plata, Y.
    Alcaide, J.
    Galeote, A.
    Pajares, B.
    Saez, E.
    Alba, E.
    Sanchez-Munoz, A.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (07) : 922 - 927
  • [10] International Agency for Research on Cancer, 2020, GLOBOCAN